Enzene Sees Tariff Exemptions For India, Front-Ends US Capacity

 
• By Vibha Ravi
  
Himanshu Gadgil, CEO, Enzene Biosciences
Himanshu Gadgil, CEO, Enzene Biosciences (Enzene Biosciences Ltd)

More from India

More from Strategy